Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners

Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (39)

  1. Must Psilocybin Always "Assist Psychotherapy"? 2024-01-01 · Expand citations
  2. Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training? 2023-03-02 · Expand citations
  3. Psychedelic Drug Legislative Reform and Legalization in the US. 2023-01-01 · Expand citations
  4. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. 2022-08-01 · Expand citations
  5. A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing 2021-09-16 · Expand citations
  6. Psychedelics, Sociality, and Human Evolution. 2021-01-01 · Expand citations
  7. Developing Guidelines and Competencies for the Training of Psychedelic Therapists 2017-06-29 · Expand citations
  8. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  9. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  10. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. 2006-08-01 · Expand citations
  11. OpenAlex W1979290264
  12. OpenAlex W2143350277
  13. OpenAlex W2541735118
  14. OpenAlex W2610144880
  15. OpenAlex W2739506888
  16. OpenAlex W3023499422
  17. OpenAlex W3198659533
  18. OpenAlex W3215626177
  19. OpenAlex W4210764005
  20. OpenAlex W4236038590
  21. OpenAlex W4241052343
  22. OpenAlex W4244982232
  23. OpenAlex W4245006944
  24. OpenAlex W4248607037
  25. OpenAlex W4251929576
  26. OpenAlex W4255816404
  27. OpenAlex W4281891940
  28. OpenAlex W4283584241
  29. OpenAlex W4285091545
  30. OpenAlex W4289522809
  31. OpenAlex W4319765908
  32. OpenAlex W4361248485
  33. OpenAlex W4386827794
  34. OpenAlex W4387521434
  35. OpenAlex W4387580925
  36. OpenAlex W4387763972
  37. OpenAlex W4399215777
  38. OpenAlex W63354357
  39. OpenAlex W6804346829

Cited by — these papers cite this paper (1)

  1. Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development 2026-07-03 · Expand citations